Westerkirk Capital »

Amgen shares owned by Westerkirk Capital

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Westerkirk Capital from 13F filings

Historical chart of Westerkirk Capital investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Westerkirk Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Westerkirk Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $669k 2.4k 282.20

More positions owned by Westerkirk Capital

Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Mastercard Incorporated Cl A (MA)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
TJX Companies (TJX)
Canadian Pacific Kansas City (CP)

View all positions for Westerkirk Capital

Top funds holding Amgen

Vanguard Group
BlackRock
State Street Corporation
Capital Research and Management Company - Division 3
Capital World Investors
Morgan Stanley
Charles Schwab Investment Management
Geode Capital Management
PRIMECAP Management Company
Wells Fargo & Company
Northern Trust
Capital Research Global Investors
Royal Bank of Canada
Ubs Global Asset Management Americas
Goldman Sachs Group

View all funds holding Amgen